Generating societal and economic value by studying innovative drug concepts
The BDDD programme works on the improvement of drugs and technologies used in drug development, production, administration, and safety assessment. The emphasis is on therapies for age-related diseases (e.g. fibrotic diseases, COPD, and cancer), in accordance with the UMCG’s focus on healthy ageing.
Collaborations have been set up with other researchers from the GUIDE institute and the UMCG, as well as with external parties, including industrial partners. The top-notch research performed in our programme offers an attractive environment for young, talented researchers and has already yielded concrete results:
- Reduction in the use of animals in disease- and drug safety-related research;
- New inhalation devices and vaccine formulation strategies;
- Gene doping detection by next generation sequencing.